LOS ANGELES, Nov. 15, 2016 /PRNewswire/
-- StockNewsNow.com, The Official MicroCap News Source™, today
published SNNLive Video Interview with Thomas Keuer, Chief Operating Officer of ARCA
biopharma, Inc. (NASDAQ: ABIO) a biopharmaceutical company applying
a precision medicine approach to the development of
genetically-targeted therapies for cardiovascular diseases,
according to the company's website (see here: www.ARCAbio.com). The
video interview was recorded on Thursday,
October 20th, 2016 at the Dawson James Small Cap
Growth Conference 2016 in Jupiter,
FL.
Click the following link to watch the SNNLive Video Interview on
StockNewsNow.com:
ARCA biopharma, Inc. – Focused on Developing
Genetically-targeted Therapies for Cardiovascular Diseases
You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN,
YOUTUBE, and STOCKTWITS
Please review important disclosures on our website at:
http://stocknewsnow.com/legal.php#disclaimer
About ARCA biopharma, Inc.
ARCA biopharma is dedicated to developing genetically-targeted
therapies for cardiovascular diseases through a precision medicine
approach to drug development. The Company's lead product
candidate, Gencaro™ (bucindolol hydrochloride),
is an investigational, pharmacologically unique beta-blocker and
mild vasodilator being developed for atrial fibrillation.
ARCA has identified common genetic variations that it
believes predict individual patient response to Gencaro, giving it
the potential to be the first genetically-targeted atrial
fibrillation prevention treatment. ARCA has a collaboration
with Medtronic, Inc. for support of the GENETIC-AF trial. For
more information and company description, please
visit www.arcabio.com.
About StockNewsNow.com
StockNewsNow.com is a microcap financial news portal that
features news and insights from the microcap and emerging growth
financial community. StockNewsNow.com is a multimedia destination
hub for information about microcap and emerging growth public and
private companies, market events, news, bulletins, stock quotes,
expert commentary and company profiles that feature SNN-produced
video like SNNLive CEO video interviews, as well as their latest
news and headlines. Users can engage directly and share the
information provided through social media.
Follow the companies YOU want to know more about; read and watch
content from YOUR favorite microcap, emerging growth financial
experts; register to attend financial conferences of YOUR choosing;
find microcap and emerging growth financial professionals that YOU
may be looking for - all here on StockNewsNow.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/stocknewsnowcom-publishes-new-snnlive-video-interview-with-arca-biopharma-inc-provides-company-overview-and-discusses-clinical-development-300363117.html
SOURCE StockNewsNow.com